🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the safety, tolerability and activit...
Status
Withdrawn
Location
Dept. of Hematology and Oncology, Charité, Campus Charité Mitte
Start Date
2010-05
Trial ID
NCT01170052
Treatments Being Tested
This study will determine whether a drug called sirolimus is safe to give t...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2011-09
Trial ID
NCT01445548
Treatments Being Tested
RATIONALE: Giving low doses of chemotherapy, such as fludarabine and cyclop...
Status
Terminated
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2008-06-23
Trial ID
NCT00489281
To evaluate the response to chemotherapy with the drug decitabine combined ...
Status
Completed
Location
University of Rochester
Start Date
2014-03
Trial ID
NCT02109744
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of auranofin w...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2014-05-14
Trial ID
NCT01737502
Treatments Being Tested
This phase II trial tests the effect of total marrow and lymphoid irradiati...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2027-04-05
Trial ID
NCT07582172
The purpose of this study is to assess the efficacy of nonpolymer-based rap...
Status
Completed
Location
Deutsches Herzzentrum Muenchen
Start Date
2004-03
Trial ID
NCT00140530
Treatments Being Tested
The investigators will perform a two-center phase I trial of celecoxib (COX...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2016-06-15
Trial ID
NCT02484664
Treatments Being Tested
The purpose of this study is to examine the effects of rapamycin (sirolimus...
Status
Completed
Location
Medical University of South Carolina
Start Date
2018-10-01
Trial ID
NCT04161144
The purpose of this study is to obtain data on the effectiveness and safety...
Status
Terminated
Location
Multiple Locations
Start Date
2001-04
Trial ID
NCT00240214
Treatments Being Tested